Sanofi Target of Unusually Large Options Trading (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) was the recipient of unusually large options trading on Thursday. Stock investors acquired 6,242 call options on the stock. This is an increase of 276% compared to the average volume of 1,658 call options.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Mondrian Investment Partners LTD boosted its stake in Sanofi by 43.1% during the first quarter. Mondrian Investment Partners LTD now owns 3,951,089 shares of the company’s stock valued at $192,023,000 after buying an additional 1,190,141 shares in the last quarter. Armistice Capital LLC bought a new position in Sanofi during the fourth quarter valued at about $51,520,000. Bank of New York Mellon Corp boosted its stake in Sanofi by 16.5% during the first quarter. Bank of New York Mellon Corp now owns 7,224,508 shares of the company’s stock valued at $351,111,000 after buying an additional 1,021,077 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in Sanofi by 3,440.6% during the first quarter. BNP Paribas Financial Markets now owns 1,033,549 shares of the company’s stock valued at $50,230,000 after buying an additional 1,004,358 shares in the last quarter. Finally, Morningstar Investment Services LLC boosted its stake in Sanofi by 99.5% during the fourth quarter. Morningstar Investment Services LLC now owns 1,486,949 shares of the company’s stock valued at $73,425,000 after buying an additional 741,456 shares in the last quarter. 10.04% of the stock is owned by institutional investors and hedge funds.

Sanofi Stock Performance

NASDAQ SNY traded up $0.18 during trading hours on Thursday, hitting $51.21. The company had a trading volume of 1,785,732 shares, compared to its average volume of 2,144,123. Sanofi has a fifty-two week low of $42.63 and a fifty-two week high of $55.72. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The business has a fifty day simple moving average of $48.80 and a 200-day simple moving average of $48.63. The firm has a market cap of $129.70 billion, a P/E ratio of 25.64, a price-to-earnings-growth ratio of 1.56 and a beta of 0.59.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, April 25th. The company reported $0.96 earnings per share for the quarter, hitting the consensus estimate of $0.96. The firm had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. Equities analysts predict that Sanofi will post 4.14 EPS for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.